PALO ALTO, Calif., March 29, 2004 Varian Medical Systems, Inc., (NYSE:VAR) today announced it has successfully completed the acquisition of the assets of Denver-based OpTx, a privately-held supplier of software for medical oncology practices in cancer clinics. Varian paid approximately $18 million in cash to acquire the OpTx assets, including the OpTxTools™ software, which it will continue to develop, sell, install, and service worldwide as a stand-alone product for medical oncology practices and as part of its VARiS™ software for coordination with radiation oncology. The acquisition is expected to add annualized revenues of $9 million and be nearly neutral to earnings for the company in fiscal year 2004.
The acquisition will enable Varian to offer an integrated single software system for managing and coordinating radiation therapy and chemotherapy routinely used in the treatment of cancer.
“The OpTx technology will help Varian to provide more comprehensive management software that makes multi-modality cancer treatments better, faster, easier, and more cost effective,” said Richard M. Levy, chairman and CEO of Varian Medical Systems.
The OpTx assets are now part of Varian’s Oncology Systems business segment.